- Fellowship - Emory University School of Medicine (2019-2022), Pediatric Hematology/oncology
- Residency - Washington University in St. Louis School of Medicine (2016-2019), Pediatrics
- Medical School - Virginia Commonwealth University School of Medicine (2012-2016)
Arhanti Sadanand, M.D.
- Pediatrics - Hematology-Oncology
- Pediatric solid tumors
Arhanti Sadanand, M.D., is an Assistant Professor in the Department of Pediatrics at UT Southwestern Medical Center. She specializes in pediatric solid tumors and neuroblastoma.
Dr. Sadanand earned her medical degree at the Virginia Commonwealth University School of Medicine. She completed her residency in pediatrics at Washington University in Saint Louis and St. Louis Children’s Hospital, followed by a fellowship in pediatric hematology/oncology at Emory University and Children’s Healthcare of Atlanta.
Certified by the American Board of Pediatrics, she joined the UT Southwestern faculty in 2022.
Dr. Sadanand is a member of the Children’s Oncology Group, the American Academy of Pediatrics, and the American Society of Pediatric Hematology/Oncology.
She says, “I'm passionate about pediatric oncology and am honored by the opportunity to care for children and their families during difficult moments.”
Education & Training
Professional Associations & Affiliations
- American Academy of Pediatrics
- American Society of Pediatric Hematology/Oncology
Honors & Awards
- Best of Winship at Virtual Poster Session 2021, Winship Cancer Institute of Emory University
- Resident Patient Safety and Quality Improvement Showcase Award 2018, Saint Louis Children’s Hospital
- James P. Keating Outstanding Resident Award 2017, Saint Louis Children’s Hospital
- Alpha Omega Alpha Honor Medical Society, Brown-Séquard Chapter 2015, Virginia Commonwealth University School of Medicine
Books & Publications
Development of a Medical Spanish Curriculum for Fourth-Year Medical Students.
Sadanand A, Ryan MH, Cohen S, Ryan MS, PRiMER (Leawood, Kan.) 2018 2 17
Case 1: Syncope in a 16-year-old Girl.
Sadanand A, Ladell M, Fischer K, Pediatrics in review 2019 Jan 40 1 37-39
A single-center retrospective review of pediatric cases of progressive transformation of germinal centers.
Sadanand A, Aljudi A, Bergsagel DJ, Keller FG, Pediatric blood & cancer 2023 Jun 70 6 e30283
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
Cash T, Jonus HC, Tsvetkova M, Beumer JH, Sadanand A, Lee JY, Henry CJ, Aguilera D, Harvey RD, Goldsmith KC, Pediatric blood & cancer 2023 May e30405
Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States.
Papanicolaou GA, Dvorak CC, Dadwal S, Maron G, Prasad VK, Giller R, Abdel-Azim H, Sadanand A, Casciano R, Chandak A, Huang S, Nichols G, Brundage T, Vainorius E, Mozaffari E, Hutcheson R, Transplant infectious disease : an official journal of the Transplantation Society 2020 Aug 22 4 e13283
Teaching scripts via smartphone app facilitate resident-led teaching of medical students.
Zessis NR, Dube AR, Sadanand A, Cole JJ, Hrach CM, Daud YN, BMC medical education 2021 Jun 21 1 331
Memory's penumbra: episodic memory decisions induce lingering mnemonic biases.
Duncan K, Sadanand A, Davachi L, Science (New York, N.Y.) 2012 Jul 337 6093 485-7
Non-Neural (S-100 Negative) Bronchial Granular Cell Tumor Causing Acute Respiratory Failure.
Chen SY, Sadanand A, Dillon PA, He M, Dehner LP, Leonard DS, Fetal and pediatric pathology 2020 Feb 39 1 85-89
Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients.
Sadanand A, Newland JG, Bednarski JJ, Infectious diseases and therapy 2019 Jun 8 2 301-306
Burkitt Lymphoma Presenting as a Paraneoplastic Demyelinating Disorder in a Child
Arhanti Sadanand, Juhi Jain , Kathryn Elkins , Daniel John Bergsagel Journal of Pediatric Neurology 2022 2 113-114
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R, Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Oct JCO2201273
- Development of a Medical Spanish Curriculum for Fourth-Year Medical Students.
- Improving survival from neuroblastoma
- Pediatric solid tumors